Aigen Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,084
Closed -$1.13M 642
2025
Q3
$1.13M Buy
+14,084
New +$1.2M 0.17% 176
2024
Q1
Sell
-9,444
Closed -$753K 716
2023
Q4
$753K Buy
+9,444
New +$710K 0.13% 220
2023
Q3
Sell
-3,343
Closed -$258K 863
2023
Q2
$258K Sell
3,343
-5,614
-63% -$435K 0.04% 538
2023
Q1
$673K Buy
8,957
+5,019
+127% +$373K 0.09% 260
2022
Q4
$310K Sell
3,938
-4,621
-54% -$346K 0.04% 357
2022
Q3
$601K Sell
8,559
-1,591
-16% -$125K 0.09% 275
2022
Q2
$813K Sell
10,150
-40,025
-80% -$3.13M 0.14% 213
2022
Q1
$3.81M Buy
50,175
+37,530
+297% +$2.97M 0.66% 32
2021
Q4
$976K Sell
12,645
-13,601
-52% -$1.06M 0.06% 428
2021
Q3
$1.98M Buy
+26,246
New +$2.08M 0.38% 73
2021
Q2
Sell
-62,276
Closed -$4.91M 512
2021
Q1
$4.91M Buy
+62,276
New +$4.88M 0.65% 39
2020
Q2
Sell
-2,989
Closed -$198K 886
2020
Q1
$198K Buy
+2,989
New +$211K 0.03% 712

Other funds holding CL

Aigen Investment Management's CL Position: Q4 2025 in Review

Aigen Investment Management sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 14,084 shares — an estimated $1.13M sold.

Aigen Investment Management first reported a position in CL in Q1 2020 and held it in 12 quarters. The position peaked at $4.91M in Q1 2021. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Aigen Investment Management reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 14,084 Colgate-Palmolive shares in Q4 2025, an estimated $1.13M.
  • Aigen Investment Management first reported a position in Colgate-Palmolive in Q1 2020 and held it in 12 quarters.
  • Aigen Investment Management's Colgate-Palmolive position peaked at $4.91M in Q1 2021.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.